View in EDS HTML Full Text PDF Full Text

Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversion.

Saved in:
Bibliographic Details
Title: Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversion.
Authors: Wilk EJ; The Department of Cell, Developmental and Integrative Biology, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA., Howton TC; The Department of Cell, Developmental and Integrative Biology, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA., Fisher JL; The Department of Cell, Developmental and Integrative Biology, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA., Oza VH; The Department of Cell, Developmental and Integrative Biology, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA., Brownlee RT; The Department of Cell, Developmental and Integrative Biology, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA.; Department of Biomedical Sciences, Mercer University, Macon, GA, USA., McPherson KC; The Department of Cell, Developmental and Integrative Biology, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA., Cleary HL; The Department of Cell, Developmental and Integrative Biology, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA.; University of Kentucky College of Medicine, Lexington, KY, USA., Yoder BK; The Department of Cell, Developmental and Integrative Biology, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA., George JF; The Department of Surgery, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA., Mrug M; The Department of Medicine, HeersinkSchool of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA.; Department of Veterans Affairs Medical Center, Birmingham, AL, USA., Lasseigne BN; The Department of Cell, Developmental and Integrative Biology, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA. bnp0001@uab.edu.
Source: Molecular medicine (Cambridge, Mass.) [Mol Med] 2023 May 22; Vol. 29 (1), pp. 67. Date of Electronic Publication: 2023 May 22.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 9501023 Publication Model: Electronic Cited Medium: Internet ISSN: 1528-3658 (Electronic) Linking ISSN: 10761551 NLM ISO Abbreviation: Mol Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37217845
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversion.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Wilk+EJ%22">Wilk EJ</searchLink>; The Department of Cell, Developmental and Integrative Biology, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA.<br /><searchLink fieldCode="AU" term="%22Howton+TC%22">Howton TC</searchLink>; The Department of Cell, Developmental and Integrative Biology, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA.<br /><searchLink fieldCode="AU" term="%22Fisher+JL%22">Fisher JL</searchLink>; The Department of Cell, Developmental and Integrative Biology, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA.<br /><searchLink fieldCode="AU" term="%22Oza+VH%22">Oza VH</searchLink>; The Department of Cell, Developmental and Integrative Biology, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA.<br /><searchLink fieldCode="AU" term="%22Brownlee+RT%22">Brownlee RT</searchLink>; The Department of Cell, Developmental and Integrative Biology, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA.; Department of Biomedical Sciences, Mercer University, Macon, GA, USA.<br /><searchLink fieldCode="AU" term="%22McPherson+KC%22">McPherson KC</searchLink>; The Department of Cell, Developmental and Integrative Biology, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA.<br /><searchLink fieldCode="AU" term="%22Cleary+HL%22">Cleary HL</searchLink>; The Department of Cell, Developmental and Integrative Biology, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA.; University of Kentucky College of Medicine, Lexington, KY, USA.<br /><searchLink fieldCode="AU" term="%22Yoder+BK%22">Yoder BK</searchLink>; The Department of Cell, Developmental and Integrative Biology, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA.<br /><searchLink fieldCode="AU" term="%22George+JF%22">George JF</searchLink>; The Department of Surgery, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA.<br /><searchLink fieldCode="AU" term="%22Mrug+M%22">Mrug M</searchLink>; The Department of Medicine, HeersinkSchool of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA.; Department of Veterans Affairs Medical Center, Birmingham, AL, USA.<br /><searchLink fieldCode="AU" term="%22Lasseigne+BN%22">Lasseigne BN</searchLink>; The Department of Cell, Developmental and Integrative Biology, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA. bnp0001@uab.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229501023%22">Molecular medicine (Cambridge, Mass.)</searchLink> [Mol Med] 2023 May 22; Vol. 29 (1), pp. 67. <i>Date of Electronic Publication: </i>2023 May 22.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9501023 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1528-3658 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210761551%22">10761551 </searchLink><i>NLM ISO Abbreviation: </i>Mol Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37217845
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s10020-023-00664-z
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 67
    Titles:
      – TitleFull: Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversion.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wilk EJ
      – PersonEntity:
          Name:
            NameFull: Howton TC
      – PersonEntity:
          Name:
            NameFull: Fisher JL
      – PersonEntity:
          Name:
            NameFull: Oza VH
      – PersonEntity:
          Name:
            NameFull: Brownlee RT
      – PersonEntity:
          Name:
            NameFull: McPherson KC
      – PersonEntity:
          Name:
            NameFull: Cleary HL
      – PersonEntity:
          Name:
            NameFull: Yoder BK
      – PersonEntity:
          Name:
            NameFull: George JF
      – PersonEntity:
          Name:
            NameFull: Mrug M
      – PersonEntity:
          Name:
            NameFull: Lasseigne BN
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 22
              M: 05
              Text: 2023 May 22
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1528-3658
          Numbering:
            – Type: volume
              Value: 29
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Molecular medicine (Cambridge, Mass.)
              Type: main
ResultId 1